Learning from Clinical Setbacks in Obesity to Accelerate Treatment in Segmented Subgroups

Time: 1:30 pm
day: Day One


  • Evaluating recent clinical setbacks in developing an oral insulin formulation for T2D to control blood sugar
  • Spotlighting challenges in oral delivery and sustained treatment
  • Leveraging silver linings: identifying a patient subgroup that met the primary endpoint for weight-loss